article thumbnail

A Look Ahead: Key Intellectual Property Legal Topics in 2024

JD Supra Law

What should in-house counsel be on the lookout for in 2024? As we begin a new year, our attorneys look ahead at intellectual property topics they expect will be trending in 2024. They cover areas including life sciences, litigation, post-grant proceedings, artificial intelligence, design patents, and trademarks.

article thumbnail

Extension of the Deadline for the 2024 Shamnad Basheer Essay Competition on Intellectual Property Law – 28th July, 2024 

SpicyIP

With several requests for extensions coming in, we’ve decided to extend the deadline for the 2024 Shamnad Basheer Essay Competition on Intellectual Property Law. The new deadline is 28th July, 2024 (11:59 pm IST). Shamnad Basheer 1976-2019; taken at NUJS, Kolkata circa 2009.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Australian Intellectual Property Reforms Ahead

JD Supra Law

2024 appears to be a year of change in the Australian Intellectual Property realm, with the adoption by IP Australia of the Madrid Goods and Services List and the introduction of the Intellectual Property Laws Amendment (Regulator Performance) Act 2023. By: International Lawyers Network

article thumbnail

WIPO Member States Adopt New Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge

JD Supra Law

On May 24, 2024, member states of the World Intellectual Property Organization (WIPO) adopted a new treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge that was over 20 years in the making. By: Knobbe Martens

article thumbnail

Infographic | INTA meeting 2024

Olartemoure Blog

They study past, present, and future trends in branding, covering both the philosophy and economics of trademarks and their interaction with other intellectual property rights and issues such as consumer law, unfair competition, copyright, antitrust, and entertainment. Pava and J. Felipe Acosta, were present.

article thumbnail

3 Key Takeaways - From the New York City Bar Association's 2024 Intellectual Property Institute

JD Supra Law

Kilpatrick was honored to be a Platinum sponsor of the New York City Bar Association’s 2024 Intellectual Property Institute. Jonathan W. Thomas, Megan E.

article thumbnail

Mylan Pharms. Inc. v. Bayer Intellectual Property GmbH, C.A. - Xarelto® (Rivaroxaban)

JD Supra Law

Bayer Intellectual Property GmbH, C.A. 23-556-RGA, 2024 WL 359468 (D. 31, 2024) (Hatcher, M.J.) - Drug Product and Patent(s)-in-Suit: Xarelto® (rivaroxaban); U.S. Case Name: Mylan Pharms. Patents Nos. 7,157,456 (“the ’456 patent”), 9,415,053 (“the ’053 patent”), and 10,828,310 (“the ’310 patent”). By: Robins Kaplan LLP